Bergen, Norway, 16 February 2018 - On 9 March 2018 at 11:00 hours (CET) an
extraordinary general meeting of BerGenBio ASA will be held in the Company's
offices in Jonas Lies vei 91, 5009 Bergen.
The notice, registration form and power of attorney are attached to this
release. The notice will be sent to all registered shareholders.
For further information, please contact:
-End-
Contacts
Richard Godfrey
CEO, BerGenBio ASA
+47 917 86 304
Tom Henrik Sundby
Finance Director, BerGenBio ASA
tom.sundby@bergenbio.com
+47 477 54 415
Forward looking statements
This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this announcement by such forward-looking statements
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.